Parametric Portfolio Associates LLC Reduces Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Parametric Portfolio Associates LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 319,253 shares of the medical equipment provider’s stock after selling 23,275 shares during the period. Parametric Portfolio Associates LLC’s holdings in Intuitive Surgical were worth $167,464,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Manchester Financial Inc. acquired a new position in shares of Intuitive Surgical during the second quarter worth about $25,000. Icon Wealth Partners LLC acquired a new position in Intuitive Surgical during the first quarter worth approximately $26,000. Advisory Alpha LLC bought a new stake in Intuitive Surgical in the 1st quarter valued at $32,000. Glassman Wealth Services lifted its stake in shares of Intuitive Surgical by 207.7% during the 1st quarter. Glassman Wealth Services now owns 80 shares of the medical equipment provider’s stock worth $46,000 after buying an additional 54 shares during the last quarter. Finally, FNY Investment Advisers LLC bought a new stake in shares of Intuitive Surgical during the second quarter worth approximately $47,000. 85.97% of the stock is owned by institutional investors and hedge funds.

In other news, COO Salvatore Brogna sold 1,171 shares of the company’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $505.23, for a total value of $591,624.33. Following the transaction, the chief operating officer now owns 5,933 shares of the company’s stock, valued at $2,997,529.59. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Curet Myriam sold 4,974 shares of the company’s stock in a transaction dated Tuesday, July 23rd. The stock was sold at an average price of $532.14, for a total value of $2,646,864.36. Following the completion of the transaction, the executive vice president now owns 3,851 shares in the company, valued at $2,049,271.14. The disclosure for this sale can be found here. Insiders have sold 25,869 shares of company stock valued at $13,664,252 over the last ninety days. 1.70% of the stock is currently owned by company insiders.

ISRG has been the topic of a number of research analyst reports. Northland Securities set a $375.00 target price on shares of Intuitive Surgical and gave the company a “sell” rating in a research report on Friday, July 19th. ValuEngine cut shares of Intuitive Surgical from a “hold” rating to a “sell” rating in a research report on Friday, July 12th. UBS Group set a $560.00 price target on Intuitive Surgical and gave the company a “hold” rating in a research note on Friday, July 19th. Piper Jaffray Companies boosted their target price on Intuitive Surgical from $610.00 to $633.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Finally, Morgan Stanley set a $620.00 price objective on shares of Intuitive Surgical and gave the company a “buy” rating in a report on Friday, July 19th. Three investment analysts have rated the stock with a sell rating, four have given a hold rating and nine have assigned a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $579.92.

ISRG stock traded up $20.20 during trading on Wednesday, reaching $522.50. The stock had a trading volume of 498,912 shares, compared to its average volume of 579,779. The company has a market capitalization of $57.25 billion, a price-to-earnings ratio of 55.06, a P/E/G ratio of 3.84 and a beta of 1.13. Intuitive Surgical, Inc. has a one year low of $430.24 and a one year high of $589.32. The company’s 50 day moving average is $508.54 and its two-hundred day moving average is $522.33.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 18th. The medical equipment provider reported $3.25 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.23 by $1.02. Intuitive Surgical had a net margin of 29.95% and a return on equity of 17.35%. The firm had revenue of $1.10 billion for the quarter, compared to analysts’ expectations of $1.03 billion. During the same quarter last year, the firm earned $2.76 EPS. The company’s quarterly revenue was up 20.9% compared to the same quarter last year. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 10.12 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Further Reading: What is the S&P 500 Index?

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.